Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Christian Tientcha Happi, Ph.D.

Co-Author

Back to Details
This page shows the publications co-authored by Christian Happi and Stephen Schaffner.
Christian Happi
Connection Strength
1.504
Stephen Schaffner
  1. The Origins and Future of Sentinel: An Early-Warning System for Pandemic Preemption and Response. Viruses. 2021 08 13; 13(8).
    View in: PubMed
    Score: 0.238
  2. Real-time Metagenomic Analysis of Undiagnosed Fever Cases Unveils a Yellow Fever Outbreak in Edo State, Nigeria. Sci Rep. 2020 02 21; 10(1):3180.
    View in: PubMed
    Score: 0.215
  3. Genomic Analysis of Lassa Virus during an Increase in Cases in Nigeria in 2018. N Engl J Med. 2018 11 01; 379(18):1745-1753.
    View in: PubMed
    Score: 0.196
  4. Ebola Virus Epidemiology and Evolution in Nigeria. J Infect Dis. 2016 10 15; 214(suppl 3):S102-S109.
    View in: PubMed
    Score: 0.167
  5. Discovery of novel rhabdoviruses in the blood of healthy individuals from West Africa. PLoS Negl Trop Dis. 2015 Mar; 9(3):e0003631.
    View in: PubMed
    Score: 0.153
  6. A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa. Science. 2021 Oct 22; 374(6566):423-431.
    View in: PubMed
    Score: 0.060
  7. Development of a qualitative real-time RT-PCR assay for the detection of SARS-CoV-2: a guide and case study in setting up an emergency-use, laboratory-developed molecular microbiological assay. J Clin Pathol. 2021 Aug; 74(8):496-503.
    View in: PubMed
    Score: 0.059
  8. Development of a qualitative real-time RT-PCR assay for the detection of SARS-CoV-2: A guide and case study in setting up an emergency-use, laboratory-developed molecular assay. medRxiv. 2020 Sep 01.
    View in: PubMed
    Score: 0.056
  9. Deployable CRISPR-Cas13a diagnostic tools to detect and report Ebola and Lassa virus cases in real-time. Nat Commun. 2020 08 17; 11(1):4131.
    View in: PubMed
    Score: 0.056
  10. Clinical and laboratory predictors of Lassa fever outcome in a dedicated treatment facility in Nigeria: a retrospective, observational cohort study. Lancet Infect Dis. 2018 06; 18(6):684-695.
    View in: PubMed
    Score: 0.047
  11. Virus genomes reveal factors that spread and sustained the Ebola epidemic. Nature. 2017 04 20; 544(7650):309-315.
    View in: PubMed
    Score: 0.044
  12. Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus. Cell. 2015 Aug 13; 162(4):738-50.
    View in: PubMed
    Score: 0.039
  13. Ebola Virus Epidemiology, Transmission, and Evolution during Seven Months in Sierra Leone. Cell. 2015 Jun 18; 161(7):1516-26.
    View in: PubMed
    Score: 0.039
  14. Clinical illness and outcomes in patients with Ebola in Sierra Leone. N Engl J Med. 2014 Nov 27; 371(22):2092-100.
    View in: PubMed
    Score: 0.037
  15. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science. 2014 Sep 12; 345(6202):1369-72.
    View in: PubMed
    Score: 0.037
  16. Epidemiology. Emerging disease or diagnosis? Science. 2012 Nov 09; 338(6108):750-2.
    View in: PubMed
    Score: 0.032
  17. Identification and functional validation of the novel antimalarial resistance locus PF10_0355 in Plasmodium falciparum. PLoS Genet. 2011 Apr; 7(4):e1001383.
    View in: PubMed
    Score: 0.029
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.